Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 11305 - 11312 of 12007 results
ML Strategies Publishes Weekly Health Care Reform Update on September 10, 2012
September 11, 2012| Blog| Viewpoint
Broad new data security rule proposed for federal contractors
September 11, 2012| Blog| Viewpoint
IRS Issues Rules on "Full-time Employees" and 90-day Waiting Period Limitation under the Affordable Care Act
September 10, 2012| Blog| Viewpoint
FTC to Mobile App Developers: Get Privacy Right from the Start
September 5, 2012| Blog| Viewpoint
Wyndham Motion Puts the FTC on the Defensive
August 31, 2012| Blog| Viewpoint
HHS Clarifies Temporary Enforcement Safe Harbor for Contraceptive Services under Plans of Certain Religious Employers
August 29, 2012| Blog| Viewpoint
Politician Settling Case for Unauthorized Use of Music at Campaign Events
August 29, 2012| Blog| Viewpoint
EU Chamber of Commerce in China Report on Innovation
August 28, 2012| Blog| Viewpoint
News & Press Releases
Mintz advised ArriVent BioPharma, Inc., a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers, on a $75 million underwritten public offering of 2,482,692 shares of its common stock and pre-funded warrants to purchase up to 1,363,469 shares of its common stock. The common stock is listed on The Nasdaq Global Market under the symbol “AVBP.“
Mintz represented S2G Investments, a multi-stage investment firm focused on venture and growth-stage businesses across food & agriculture, oceans and energy, in its $40 million Series B financing of Sojo Industries, an industrial automation company that utilizes robotics, mobility, and software to deliver packaging and assembly solutions to the food and beverage industry.
Mintz advised Syntis Bio, a clinical-stage biopharmaceutical company revolutionizing oral therapies for obesity, diabetes, and rare diseases, on a $33 million oversubscribed Series A financing.
Events
Mintz x The Engine: Supercharging Your IP Strategy with Trade Secrets
The Engine, 750 Main St. Cambridge, MA 02139
Podcasts
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
Mintz On Air: Practical Policies – An Abridged Guide to Crisis Management
July 1, 2025| Podcast|